Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 24, 2023

Survival of Patients With Cancer With DPYD Variant Alleles Receiving Dose-Individualized Fluoropyrimidine Therapy

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair Analysis
J. Clin. Oncol 2023 Aug 28;[EPub Ahead of Print], JE Knikman, TA Wilting, M Lopez-Yurda, LM Henricks, CATC Lunenburg, FM de Man, DM Meulendijks, P Nieboer, HJ Droogendijk, GJ Creemers, CMPW Mandigers, ALT Imholz, RHJ Mathijssen, JEA Portielje, L Valkenburg-van Iersel, A Vulink, MHW van der Poel, A Baars, JJ Swen, H Gelderblom, JHM Schellens, JH Beijnen, HJ Guchelaar, A Cats

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading